Clinical Summary:
The Gap: Functional Neurological Disorder is more common than multiple sclerosis, has positive diagnostic signs at 90-100% specificity, and has an evidence-based multidisciplinary rehabilitation pathway. Most non-specialist clinicians received no formal training in any of these.
The Evidence: 5-15% of neurology clinic patients. Hoover's sign, tremor entrainment, tubular vision rule it in. Physio4FMD established PT efficacy. Macías-García RCT favored combined PT + CBT. Multidisciplinary programs reduce ED utilization.
The Takeaway: FND is a treatable neurological condition with a positive-signs diagnostic framework and a multidisciplinary care pathway. The clinicians who learn it recognize a patient population they were previously missing or mismanaging.
The historical legacy of how FND has been talked about ("conversion disorder," "psychogenic," "hysterical," "all in their head") has caused significant iatrogenic harm. Patients with this diagnosis have endured average symptom durations of years before someone made the actual diagnosis. They have undergone unnecessary workups, accumulated unhelpful medications, and absorbed the message that their symptoms aren't real or aren't taken seriously.
The contemporary evidence has moved past all of that. Functional neurological disorder clinician guide material in 2025 starts from a different place: this is a neurological disorder with abnormal brain network function, positive diagnostic signs at 90-100% specificity, and an evidence-based multidisciplinary rehabilitation pathway. The clinicians who update on this framework recognize a patient population the rest of the system is still missing.
This pillar page is the operating model for the non-specialist clinician (PT, OT, RN, SLP, ATC, MT) who encounters FND in their caseload and wants their working knowledge to match the current evidence.
The Scale and the Misunderstanding
FND accounts for 5 to 15 percent of patients in neurology clinics, comparable in prevalence to multiple sclerosis and Parkinson disease. Annual incidence is 4-12 per 100,000, similar to MS and ALS. Functional seizures account for 20-30 percent of patients referred to epilepsy monitoring units for refractory seizures. By any reasonable measure, FND is one of the most common neurological conditions a non-specialist clinician encounters.
Yet most PT, OT, nursing, and allied health curricula provide minimal FND content. Most clinicians learn what little they know from anecdote, from the historical "psychogenic" framing, or from confused conversations with colleagues. The result: a high-prevalence condition with an evidence-based treatment pathway, recognized poorly and treated inadequately across most healthcare systems.
FND Prevalence:
5-15%
Of neurology clinic patients. More common than MS or Parkinson's disease.
What FND Actually Is
FND is a neurological condition characterized by symptoms that are involuntary and incongruent with recognized organic neurological disease patterns. The "functional" framing refers to abnormal brain network function, altered connectivity between emotional processing, prefrontal control, and motor regions, rather than to structural damage, degeneration, or inflammation.
The predictive coding model is the contemporary mechanistic framework. The brain generates predictions about expected sensory and motor states based on prior experience and context. In FND, abnormal internal predictions override normal sensory feedback, producing symptoms that are inconsistent with peripheral function. The neural machinery is the same machinery that governs normal movement and sensation; the inputs and weights are abnormal.
This model explains several clinical observations: why symptoms appear identical to those produced by structural disease, why they are experienced as involuntary by patients, why they fluctuate, why they improve with distraction, and why the diagnostic conversation itself can be therapeutic.
FND is classified in both DSM-5-TR (Functional Neurological Symptom Disorder) and ICD-11 (Dissociative Neurological Symptom Disorder). Both classification systems emphasize positive diagnosis based on clinical findings rather than diagnosis by exclusion.
Positive Signs: The Diagnostic Foundation
The contemporary diagnosis of FND rests on positive clinical signs, findings that demonstrate internal inconsistency or incongruity with organic disease patterns. The signs have high specificity, validated across multiple studies and populations. The detailed framework sits in the positive-signs diagnostic framework. The most clinically useful:
- Hoover's sign, for functional leg weakness. 90-100% specificity when properly performed. The contralateral hip extension that appears reflexively when contralateral hip flexion is tested but not on direct command.
- Drift without pronation, for functional arm weakness. The arm drifts downward without the pronation that would indicate upper motor neuron weakness.
- Tremor entrainment, for functional tremor. The tremor matches the frequency of rhythmic movement performed in another limb, or is suppressible with distraction.
- Tubular vision, for functional visual loss. The field of preserved vision does not expand with testing distance.
- Midline splitting, for functional sensory loss. Abrupt change at the body midline that is inconsistent with neuroanatomical pathways.
- Functional seizure semiology, prolonged duration, asynchronous limb movements, eye closure, preserved awareness during apparent bilateral motor activity, rapid postictal reorientation. Confirmed with video-EEG when needed.
These signs are not subtle suggestions. They are high-specificity diagnostic tools. Performed properly, they support a positive rule-in diagnosis with confidence comparable to other neurological diagnoses.
FND is diagnosed in, not ruled in by default. The positive signs framework ends the "we ruled out everything else" pattern and starts the treatment pathway.
FND Can Coexist with Organic Disease
This is the point most non-specialist clinicians miss. 10-25% of FND patients have a coexisting structural neurological condition, epilepsy, MS, stroke, Parkinson disease. The presence of organic disease does not preclude an FND diagnosis. The diagnosis of FND in patients with known organic comorbidity rests on the same positive signs used in patients without organic disease.
The implication: a patient with multiple sclerosis whose disability exceeds what the MS imaging and exam findings explain may have functional overlay on top of MS. A patient with epilepsy whose seizures don't respond to medication may have both epilepsy and functional seizures. Recognizing the overlap drives appropriate combined treatment; missing it leads to both under-treatment of the FND component and over-treatment of the organic component.
The Diagnostic Communication Conversation
The single highest-impact variable in FND outcomes (outside the structured rehabilitation) is the manner in which the diagnosis is communicated. Patients who understand and accept the diagnosis have substantially better outcomes than patients who remain confused, skeptical, or feel dismissed.
Effective FND diagnostic communication includes: clearly naming the diagnosis, validating the reality of symptoms, explaining the positive examination findings that support the diagnosis, emphasizing recovery potential, and providing a clear rationale for the recommended multidisciplinary treatment. The detailed framework sits in the diagnostic communication framework.
For non-physician clinicians: the formal diagnosis is made by a physician (typically neurology). Reinforcement of the diagnosis with consistent language and validation is within PT, OT, RN, SLP, ATC, and MT scope, and is therapeutic.
The Treatment Pathway: Multidisciplinary Rehabilitation
The contemporary evidence-based treatment for FND is multidisciplinary rehabilitation. PT, OT, CBT, and psychiatric care (where indicated) deliver coordinated treatment from a shared formulation. The components:
Physical therapy, distraction-based motor retraining, redirection of attention away from the affected body part, automatic movement promotion, novel motor tasks (walking backward, varied rhythm), graded retraining. The Physio4FMD trial (largest RCT, 355 adults randomized to specialist vs community PT) established efficacy. The Physio4FMD trial breakdown covers the protocol details.
Occupational therapy, sensory modulation assessment and intervention (Adolescent/Adult Sensory Profile), functional goal-setting using the Canadian Occupational Performance Measure, graded engagement in meaningful activities, energy conservation, vocational rehabilitation, environmental modification.
Cognitive behavioral therapy, the most extensively studied psychological intervention for FND. Psychoeducation, cognitive restructuring, behavioral activation, trigger management, self-management training. Systematic reviews show medium-sized benefits across physical symptoms, mental health, and functional outcomes. Particularly strong evidence in functional seizures.
Pharmacotherapy, limited role for core FND symptoms. SSRIs/SNRIs appropriate for treating comorbid depression and anxiety. Avoid benzodiazepines and opioids when possible, both perpetuate disability and worsen FND.
Multidisciplinary programs, outpatient (5-8 week structured curricula) and inpatient programs produce significant improvements in motor function, mental health, and quality of life. The Macías-García RCT confirmed superiority of combined PT plus CBT over psychological support alone. The transdisciplinary ambulatory care model has been associated with reduced emergency department utilization.
Physio4FMD Trial:
355
Adults randomized to specialist vs community PT for functional motor disorder. The largest RCT to date.
Product Spotlight:
Prognosis and Predictors
FND prognosis is variable. Some patients achieve dramatic and sustained improvement; others show modest gains; some demonstrate minimal response despite evidence-based treatment. Several factors consistently predict better outcomes:
Shorter symptom duration at diagnosis and treatment initiation. Understanding and acceptance of the diagnosis. Early access to evidence-based treatment. Workforce participation at baseline or return to work during treatment. Lower psychiatric comorbidity burden.
Factors predicting poorer outcomes: chronic, severe, longstanding symptoms; older age (particularly in men); significant untreated psychiatric comorbidity; poor understanding or acceptance of the diagnosis; high pain or fatigue burden; iatrogenic harm from prior management.
These predictors inform counseling and treatment intensity but should not be used to deny adequate trials of multidisciplinary care. Even chronic, severe presentations show meaningful gains with intensive inpatient programs.
Emerging and Adjunct Therapies
Several emerging interventions warrant awareness without yet warranting standard adoption:
Transcranial magnetic stimulation (TMS), non-invasive neuromodulation with preliminary positive signals in functional motor symptoms. Requires large sham-controlled trials before standard adoption given the strong placebo effect in FND populations.
Eye Movement Desensitization and Reprocessing (EMDR), the MODIFI randomized feasibility study showed reductions in PTSD symptoms, depression, anxiety, dissociation, disability, and healthcare utilization. Promising but feasibility-level evidence, not definitive efficacy.
Suggestion-based interventions including hypnosis, limited evidence base; reasonable adjunct for selected patients particularly with functional seizures and prominent dissociative symptoms.
Standard practice remains multidisciplinary rehabilitation (PT + OT + CBT + psychiatry as indicated). Emerging therapies are reasonable adjuncts for patients who have not responded to standard care.
Special Populations and Settings
Functional seizures (PNES). 20-30% of patients in epilepsy monitoring units for refractory seizures. Video-EEG confirms. CBT particularly strong in this subgroup. Antiseizure medication taper coordinated with neurology when functional seizures confirmed and epilepsy excluded.
Pediatric and adolescent FND. Distinct presentation patterns. Family involvement essential. Earlier intervention generally produces better outcomes.
Patients with significant trauma history. Phase-based trauma-focused approach appropriate, particularly when symptoms involve dissociation. Coordination with mental health required.
Functional cognitive disorder (FCD). Subjective cognitive complaints inconsistent with formal testing. SLP and neuropsychology contribute. Distinguish from early dementia (where progressive objective decline is present).
FND in acute and inpatient settings. RN role in recognition and triage particularly important. Patient education and family communication can prevent escalation cycles and unnecessary acute care utilization.
The Seven Myths Worth Updating
For non-specialist clinicians, the highest-yield updates concentrate in seven myths the contemporary evidence directly refutes. Covered in the seven FND myths the current evidence refutes. The short list: FND is neurological not psychiatric; diagnosis is positive not exclusion-based; symptoms are real not imagined; treatment exists and works; trauma is not required for diagnosis; FND is common not rare; and strengthening/compensation is not the right rehab approach.
What Comes Next: Implementation Challenges
The implementation gap for FND care is substantial. Major barriers include provider education gaps, poor care coordination, limited access to specialized services, patient stigma from prior dismissive encounters, symptom heterogeneity, and the absence of standardized outcome measures.
Strategies that help: targeted professional education, stepped care models that match treatment intensity to patient needs, dedicated FND clinics where available, advocacy for sustainable funding, and clear referral pathways. Telemedicine has reasonable utility for ongoing follow-up and patient education, particularly for access-limited populations.
Culturally sensitive, health-literate care that addresses socioeconomic barriers is essential for equitable service delivery. Vocational rehabilitation (including workplace accommodations and Individual Placement and Support principles) supports the employment retention that predicts better outcomes.
A retrospective pre-post intervention service evaluation of a transdisciplinary ambulatory FND care model found significant reductions in emergency department presentations after implementation. Comprehensive outpatient management can avert acute care utilization that is both costly and often unhelpful for FND patients. The economic case for multidisciplinary FND programs is becoming as strong as the clinical case.
The Bottom Line
Functional Neurological Disorder is a real, common, treatable neurological condition with positive diagnostic signs and an evidence-based multidisciplinary rehabilitation pathway. The historical legacy of dismissive language and exclusion-based diagnosis has caused significant iatrogenic harm. The contemporary evidence has moved past all of that. The clinicians who learn the positive-signs framework, the FND-specific rehabilitation approach, and the diagnostic communication evidence recognize a substantial patient population the rest of the healthcare system is still missing, and they offer those patients a pathway forward that's been hidden in plain sight.
FAQs
What is the most important update non-specialists need to learn from a functional neurological disorder clinician guide?
The shift from "diagnosis of exclusion" to positive-signs diagnosis. Once a clinician moves to confident rule-in diagnosis using Hoover's sign, tremor entrainment, tubular vision, and other validated positive signs, the rest of the care pathway flows from there: confident diagnostic communication, appropriate multidisciplinary referral, evidence-based rehabilitation. The diagnostic framing is the unlock.
Is FND treatable, or is it a chronic condition patients have to live with?
It is treatable. Physio4FMD established PT efficacy. Macías-García demonstrated superior outcomes from combined PT plus CBT. CBT systematic reviews show medium-sized benefits. Multidisciplinary outpatient and inpatient programs produce significant pre-post gains sustained at follow-up. Recovery potential is substantial, particularly with shorter symptom duration and earlier access to evidence-based care.
How is FND rehabilitation different from rehabilitation for stroke or MS?
The motor pathways are intact in FND. Strengthening and compensation underperform because the muscle isn't actually weak. The work is at the network level: distraction-based motor retraining, redirection of attention, automatic movement, novel motor tasks, graded retraining. Applying stroke-style protocols to FND consistently underperforms and may reinforce the illness model.
What's the role of psychology and psychiatry in FND treatment?
The same role they play in stroke, MS, or chronic pain: addressing comorbid anxiety, depression, PTSD, and pain coping. Psychology and psychiatry are part of the multidisciplinary team, not the whole team. The Macías-García RCT showed combined PT plus CBT outperformed psychological support alone, both physical and psychological treatment are needed.
How do I recognize FND in the patients I'm already seeing but not identifying?
Add Hoover's sign to your motor exam in any patient with weakness that doesn't follow a clear anatomic pattern. Watch for tremor that entrains to contralateral movement or suppresses with distraction. Note seizure semiology including eye closure, asynchronous movements, and rapid postictal reorientation. The patients are in your caseload; the question is whether you have the framework to recognize them.
What should a PT or OT do when they suspect FND in a patient who hasn't received the diagnosis yet?
Document your findings carefully (positive signs, distribution of symptoms, response to distraction). Communicate with the referring physician with specific findings. Suggest neurology consultation if the diagnosis hasn't been made. Continue rehabilitation work that aligns with FND-specific principles (distraction-based, automatic movement) rather than stroke-style strengthening even if the formal diagnosis is pending, those principles do no harm in any patient.
